|
Q1 2020
Filed on May 14, 2020
|
3,172
|
$14.08 - $91.32
$44.7K - $290K
|
|
|
Q1 2020
Filed on May 14, 2020
|
2,121
|
$24.73 - $48.34
$52.5K - $103K
|
|
|
Q1 2020
Filed on May 14, 2020
|
2,957
|
$40.65 - $71.24
$120K - $211K
|
|
|
Q1 2020
Filed on May 14, 2020
|
8,888
|
$20.68 - $38.7
$184K - $344K
|
|
|
Q1 2020
Filed on May 14, 2020
|
15,531
|
$19.16 - $59.72
$298K - $928K
|
|
|
Q1 2020
Filed on May 14, 2020
|
11,720
|
$19.54 - $27.38
$229K - $321K
|
|
|
Q1 2020
Filed on May 14, 2020
|
90,322
|
N/A
|
|
|
Q1 2020
Filed on May 14, 2020
|
19,605
|
N/A
|
|
|
Q1 2020
Filed on May 14, 2020
|
6,814
|
N/A
|
|
|
Q1 2020
Filed on May 14, 2020
|
7,335
|
$12.7 - $34.0
$93.2K - $249K
|
|
|
Q1 2020
Filed on May 14, 2020
|
13,843
|
N/A
|
|
|
Q1 2020
Filed on May 14, 2020
|
4,899
|
$36.56 - $53.93
$179K - $264K
|
|
|
Q1 2020
Filed on May 14, 2020
|
11,200
|
N/A
|
|
|
Q1 2020
Filed on May 14, 2020
|
3,445
|
$36.67 - $61.04
$126K - $210K
|
|
|
Q1 2020
Filed on May 14, 2020
|
16,849
|
$16.6 - $33.93
$280K - $572K
|
|
|
Q1 2020
Filed on May 14, 2020
|
37,934
|
N/A
|
|
|
Q1 2020
Filed on May 14, 2020
|
6,731
|
$11.92 - $32.74
$80.2K - $220K
|
|
|
Q1 2020
Filed on May 14, 2020
|
21,016
|
N/A
|
|
|
Q1 2020
Filed on May 14, 2020
|
3,259
|
$90.67 - $139.24
$295K - $454K
|
|
|
Q1 2020
Filed on May 14, 2020
|
9,672
|
$20.5 - $34.53
$198K - $334K
|
|
|
Q1 2020
Filed on May 14, 2020
|
16,670
|
$8.81 - $22.6
$147K - $377K
|
|
|
Q1 2020
Filed on May 14, 2020
|
3,881
|
$39.7 - $60.55
$154K - $235K
|
|
|
Q1 2020
Filed on May 14, 2020
|
17,564
|
$9.75 - $22.89
$171K - $402K
|
|
|
Q1 2020
Filed on May 14, 2020
|
8,537
|
$16.8 - $25.95
$143K - $222K
|
|
|
Q4 2019
Filed on Feb 11, 2020
|
9,308
|
N/A
|
|
|
Q4 2019
Filed on Feb 11, 2020
|
12,507
|
$7.86 - $14.83
$98.3K - $185K
|
|
|
Q4 2019
Filed on Feb 11, 2020
|
26,019
|
N/A
|
|
|
Q4 2019
Filed on Feb 11, 2020
|
8,978
|
N/A
|
|
|
Q4 2019
Filed on Feb 11, 2020
|
5,792
|
N/A
|
|
|
Q4 2019
Filed on Feb 11, 2020
|
4,046
|
$59.03 - $67.25
$239K - $272K
|
|
Sellas Life Sciences Group I
|
Q4 2019
Filed on Feb 11, 2020
|
66,000
|
N/A
|
|
|
Q4 2019
Filed on Feb 11, 2020
|
14,548
|
N/A
|
|
|
Q4 2019
Filed on Feb 11, 2020
|
7,462
|
N/A
|
|
|
Q4 2019
Filed on Feb 11, 2020
|
7,538
|
N/A
|
|
|
Q4 2019
Filed on Feb 11, 2020
|
2,237
|
$84.07 - $94.92
$188K - $212K
|
|
|
Q4 2019
Filed on Feb 11, 2020
|
2,200
|
$96.94 - $113.59
$213K - $250K
|
|
|
Q4 2019
Filed on Feb 11, 2020
|
29,349
|
N/A
|
|
|
Q4 2019
Filed on Feb 11, 2020
|
9,615
|
N/A
|
|
|
Q4 2019
Filed on Feb 11, 2020
|
7,257
|
$31.17 - $34.86
$226K - $253K
|
|
|
Q4 2019
Filed on Feb 11, 2020
|
29,125
|
$11.75 - $15.16
$342K - $442K
|
|
|
Q4 2019
Filed on Feb 11, 2020
|
10,112
|
$15.16 - $17.72
$153K - $179K
|
|
|
Q4 2019
Filed on Feb 11, 2020
|
3,905
|
$100.21 - $130.56
$391K - $510K
|
|
|
Q4 2019
Filed on Feb 11, 2020
|
19,487
|
$12.62 - $17.97
$246K - $350K
|
|
|
Q4 2019
Filed on Feb 11, 2020
|
9,377
|
N/A
|
|
Invesco Exch Trd Slf Idx Fd
|
Q4 2019
Filed on Feb 11, 2020
|
39,075
|
N/A
|
|
Flaherty & Crumrine Dyn Pfd
|
Q4 2019
Filed on Feb 11, 2020
|
11,162
|
N/A
|
|
Exchange Traded Concepts Tr
|
Q4 2019
Filed on Feb 11, 2020
|
56,416
|
N/A
|
|
|
Q4 2019
Filed on Feb 11, 2020
|
16,858
|
N/A
|
|
Invesco Exch Trd Slf Idx Fd
|
Q4 2019
Filed on Feb 11, 2020
|
69,450
|
N/A
|
|
|
Q4 2019
Filed on Feb 11, 2020
|
16,372
|
N/A
|
|